Table 1 |
|
|
Promoter constructs that have been exploited for breast carcinoma gene therapy |
|
| Promoter construct |
Reference |
|
|
|
| DF3/MUC1 promoter |
[37] |
| ErbB-2 promoter |
[3,27**,38] |
| ErbB-2 promoter/MUC1 enhancer |
[39] |
|
|
|
|
Vassaux and Lemoine Breast Cancer Res 2000 2:22 doi:10.1186/bcr25 |
|